The antigen secretion by ovarian cancer (CA-125) has been assessed using Radio Immune Assay (RIA) technique among a hundred ovarian cancer patients who received radiotherapy course as radical treatment. The study revealed that, the ovarian cancer commonly associated with the age groups of 30-40 years old taking a percent of 68 relative to other age groups and the antigen CA-125 does not has relation with aging. While the radiotherapy shows it is efficiency in management of ovarian cancer by reducing the antigen CA-125 level from 134 ± 13.3 U/ml to 5.5 ± 2.1 U/ml relative to normal level of CA-125 (35 U/ml). Also there is significant relationship between the
cancer stage and the level of antigen CA-125 (R2=0.98).
Ovarian cancer Radiation therapy and tumor maker Radioimmuneassay
Birincil Dil | İngilizce |
---|---|
Konular | Sağlık Kurumları Yönetimi |
Bölüm | Basic Medical Sciences |
Yazarlar | |
Yayımlanma Tarihi | 31 Temmuz 2013 |
Gönderilme Tarihi | 12 Mayıs 2013 |
Yayımlandığı Sayı | Yıl 2013 Cilt: 30 Sayı: 2 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.